JPRN-UMIN000031976
Completed
未知
Exploratory Study of Genetic Factors Related to the Inhibitory Effect of Tolvaptan on Increased Kidney Volume in Patients with Autosomal Dominant Polycystic Kidney Disease - To explore genome biomarkers for Tolvaptan efficacy in ADPKD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Autosomal Dominant Polycystic Kidney Disease
- Sponsor
- Otsuka Pharmaceutical Co.,Ltd.
- Enrollment
- 890
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who did not participate in extension Trial(Refer to ClinicalTrials.gov:NCT01280721 or NCT01214421\)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The study of investigating the genetic profiles of Exceptional Response in cancer therapies.Cancer patient who received therapies.JPRN-UMIN000016643ational Cancer Center Hospital30
Completed
Not Applicable
A study to improve our understanding of the genetic causes of swelling in babies before birthFetal oedema/hydrops with a focus on lymphatic related hydropsPregnancy and ChildbirthConditions involving the integument and temperature regulation of fetus and newbornISRCTN22076461St George’s University Hospitals NHS Foundation Trust60
Not yet recruiting
Not Applicable
Study on genetic factors in the pathogenesis of Inflammatory Bowel Disease: Gathering a matched control populatioCrohns diseaseUlcerative Colitis1001796910003816NL-OMON30241Academisch Medisch Centrum3,000
Completed
Phase 4
Investigation of Genetic Predictors of the Response to Selective Serotonin Re-Uptake Inhibitors TreatmentDepressionAntidepressantTreatment predictionMental Health - DepressionACTRN12609000295246Tartu University135
Completed
Not Applicable
Exploratory research on genetic factors in the metabolism and mechanism of action of citrulline involved in vascular agingJPRN-UMIN000048828DeNA Life Science Inc.2,000